Are you Dr. Nau?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3999 Dutchmans Ln
# 1
Louisville, KY 40207Phone+1 502-897-7300Fax+1 502-897-3332
Summary
- Dr. Jeffrey Nau, MD is an otolaryngologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky and Indiana. He is affiliated with Norton Womens and Childrens Hospital, UofL Health - UofL Hospital, and Norton Children's Hospital.
Education & Training
University of Louisville School of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2004 - 2008- University of Louisville School of MedicineInternship, Otolaryngology - Head and Neck Surgery, 2003 - 2004
University of Missouri-Columbia School of MedicineClass of 2003
Certifications & Licensure
IN State Medical License 2020 - 2025
KY State Medical License 2008 - 2025- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Clinical Trials
- A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration Start of enrollment: 2007 Apr 01
- A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy Start of enrollment: 2007 Dec 01
Publications & Presentations
PubMed
- Exostoses of the external auditory canal.Jeffrey Nau, Arun K. Gadre
Ear, Nose, & Throat Journal. 2010-06-01
Press Mentions
Oyster Point Pharma’s OC-01 Nasal Spray Meets Primary Endpoint in Phase 2 Mystic Trial in Subjects with Dry Eye DiseaseJanuary 13th, 2020
Oyster Point Announces Positive Results from Two Separate Phase 2b Clinical Trials of the Company’s Investigational Treatments for Dry Eye DiseaseOctober 24th, 2018- Oyster Point Pharma Announces Positive Results from Phase 2 Clinical Trial of the Company’s Investigational Treatment for Dry Eye DiseaseJuly 12th, 2018
- Join now to see all
Professional Memberships
- Fellow
